Page last updated: 2024-09-03

tetrahydrocurcumin and Breast Neoplasms

tetrahydrocurcumin has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alcantara, KP; Bulatao, BPI; Muangnoi, C; Nalinratana, N; Rojsitthisak, P; Sorasitthiyanukarn, FN; Truong, TH; Vajragupta, O1
Cao, HR; Fan, PH; Gao, XM; Kang, N; Lv, YH; Qiu, F; Wang, MM; Wang, YH; Yang, Y; Zhang, ZN1

Other Studies

2 other study(ies) available for tetrahydrocurcumin and Breast Neoplasms

ArticleYear
Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy.
    Carbohydrate polymers, 2022, Jul-15, Volume: 288

    Topics: Breast Neoplasms; Chitosan; Curcumin; Drug Carriers; Female; Humans; Lipids; Nanostructures; Particle Size

2022
Tetrahydrocurcumin induces G2/M cell cycle arrest and apoptosis involving p38 MAPK activation in human breast cancer cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 67

    Topics: Apoptosis; Breast Neoplasms; Cell Division; Curcumin; Enzyme Activation; G2 Phase; Humans; MCF-7 Cells; p38 Mitogen-Activated Protein Kinases

2014